Voltar
Artigo Acesso aberto Revisado por pares
BIBTEX RIS

Short communication Clinical significance of regulatory B cells in the peripheral blood of patients with oesophageal cancer

2015; Termedia Publishing House; Volume: 2; Linguagem: Inglês

10.5114/ceji.2015.52840

ISSN

1644-4124

Autores

Qian Li, Guangrong Bian, Yan Zhou, Yan Wang, Juan Hu, Xia Liu, Yancong Xu,

Tópico(s)

T-cell and B-cell Immunology

Resumo

ENWEndNote BIBJabRef, Mendeley RISPapers, Reference Manager, RefWorks, Zotero AMA Qian L, Bian G, Zhou Y, et al. Short communicationClinical significance of regulatory B cells in the peripheral blood of patients with oesophageal cancer. Central European Journal of Immunology. 2015;40(2):263-265. doi:10.5114/ceji.2015.52840. APA Qian, L., Bian, G., Zhou, Y., Wang, Y., Hu, J., & Liu, X. et al. (2015). Short communicationClinical significance of regulatory B cells in the peripheral blood of patients with oesophageal cancer. Central European Journal of Immunology, 40(2), 263-265. https://doi.org/10.5114/ceji.2015.52840 Chicago Qian, Li, Guang-Rong Bian, Yan Zhou, Yan Wang, Juan Hu, Xia Liu, and Yan Xu. 2015. "Short communicationClinical significance of regulatory B cells in the peripheral blood of patients with oesophageal cancer". Central European Journal of Immunology 40 (2): 263-265. doi:10.5114/ceji.2015.52840. Harvard Qian, L., Bian, G., Zhou, Y., Wang, Y., Hu, J., Liu, X., and Xu, Y. (2015). Short communicationClinical significance of regulatory B cells in the peripheral blood of patients with oesophageal cancer. Central European Journal of Immunology, 40(2), pp.263-265. https://doi.org/10.5114/ceji.2015.52840 MLA Qian, Li et al. "Short communicationClinical significance of regulatory B cells in the peripheral blood of patients with oesophageal cancer." Central European Journal of Immunology, vol. 40, no. 2, 2015, pp. 263-265. doi:10.5114/ceji.2015.52840. Vancouver Qian L, Bian G, Zhou Y, Wang Y, Hu J, Liu X et al. Short communicationClinical significance of regulatory B cells in the peripheral blood of patients with oesophageal cancer. Central European Journal of Immunology. 2015;40(2):263-265. doi:10.5114/ceji.2015.52840.

Referência(s)